Press "esc" to clear
Go to Advanced Search

Showing results

110 of 2244
  • Embargo expired:
    10-Jul-2018 12:05 AM EDT

Article ID: 696914

Survey Paints Mixed View of New Yorkers’ Health

NYU Langone Health

New Yorkers are getting heavier. And, like people across the country, many have difficulty sleeping and are suffering from depression. Diabetes rates in NYC remain high and racial and ethnic disparities persist.

Released:
2-Jul-2018 10:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    9-Jul-2018 4:00 PM EDT

Article ID: 697013

Gaps in Health Insurance Linked to Five-Fold Increase in Hospital Stays & ER Visits for Adults with Type 1 Diabetes

Michigan Medicine - University of Michigan

A new study finds that one in four working-age adults with type 1 diabetes had at least one gap of at least 30 days in their private health insurance, within an average of a three-year period. A temporary loss of coverage had a sizable impact on the patients’ use of health care once they got insurance again.

Released:
6-Jul-2018 6:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    9-Jul-2018 11:00 AM EDT

Article ID: 697131

Human clinical trial reveals verapamil as an effective Type 1 diabetes therapy

University of Alabama at Birmingham

Verapamil, a widely used blood pressure medication, has been found to help promote insulin production in adult subjects with recent-onset Type 1 diabetes by preserving beta cell function, when added to a standard insulin regimen. The findings mark the first effective, non-immunosuppressive therapeutic approach discovered to help target loss of beta cell function in Type 1 diabetes.

Released:
9-Jul-2018 11:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
RS6302_anath_shalev_2011_2.jpg
  • Embargo expired:
    9-Jul-2018 11:00 AM EDT

Article ID: 697142

Path to Successful Diabetes Drug Trial Began with Simple Question

University of Alabama at Birmingham

• The ultimate goal of basic biomedical research is to better the lives of patients through prevention, control or cure of disease. • Crossing that gap between the lab and bedside is difficult to achieve. • One great need for better treatment is diabetes, a disorder that afflicts one of every 10 U.S. adults and doubles the risk of early death.

Released:
9-Jul-2018 11:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 697141

Wake Forest Baptist Awarded $8 Million to Study Lifestyle Intervention for Type 2 Diabetes

Wake Forest Baptist Medical Center

The National Institutes of Health (NIH) has awarded $8 million to Wake Forest Baptist Medical Center to study cognitive decline and impairment in older adults with type 2 diabetes who are overweight or obese.

Released:
9-Jul-2018 10:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 697044

The Rising Price of Medicare Part D’s 10 Most Costly Medications

University of California San Diego Health

Researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego have found that the cost for the 10 “highest spend” medications in Medicare Part D — the U.S. federal government’s primary prescription drug benefit for older citizens — rose almost one-third between 2011 and 2015, even as the number of persons using these drugs dropped by the same amount.

Released:
5-Jul-2018 12:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
neuron_synapse_firing_iStock-479766094.jpg

Article ID: 696899

Experimental Drug Stops Parkinson’s Disease Progression in Mice

Johns Hopkins Medicine

Johns Hopkins researchers say they have developed an experimental drug, similar to compounds used to treat diabetes, that slows the progression of Parkinson’s disease itself — as well as its symptoms — in mice.

Released:
2-Jul-2018 11:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
RS21325_Thannickal-Zmijewski-6-scr_edited.jpg
  • Embargo expired:
    2-Jul-2018 11:00 AM EDT

Article ID: 696889

Metformin Reverses Established Lung Fibrosis

University of Alabama at Birmingham

Researchers have shown — for the first time — that established lung fibrosis can be reversed using a drug treatment that targets cell metabolism. This is important because, despite significant advances in the pathological mechanisms of persistent fibrosis, effective interventions are lacking.

Released:
29-Jun-2018 3:30 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    29-Jun-2018 6:30 PM EDT

Article ID: 696756

Air Pollution Contributes Significantly to Diabetes Globally

Washington University in St. Louis

New research links outdoor air pollution — even at levels deemed safe — to an increased risk of diabetes globally, according to a study from Washington University School of Medicine in St. Louis and the Veterans Affairs (VA) St. Louis Health Care System. The findings raise the possibility that reducing pollution may lead to a drop in diabetes cases in heavily polluted countries such as India and less polluted ones such as the United States.

Released:
28-Jun-2018 9:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
NDSUAmritaBanerjee618.jpg

Article ID: 696834

Study Shows Promise in Administering Insulin in Pill Form

North Dakota State University

A study by a team that includes Amrita Banerjee, assistant professor of pharmaceutical sciences at North Dakota State University, Fargo, shows promise in administering insulin in pill form. Banerjee is listed as first author in the study published in the Proceedings of the National Academy of Sciences.

Released:
28-Jun-2018 4:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

110 of 2244





Chat now!